Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
AVIX Inc, First Half Ordinary Profit Increases by 74%, Jul-Sep Ordinary Profit Increases by 30%
7836 AVIX,Inc. 【J-GAAP】
Earnings ReportAVIX,Inc. <7836> [TSE Std] announced its financial results after the market closed on November 14th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) expanded 80 million yen, an increase 73.9% compared to the same period last year. Progress toward the full-year plan of 281 million yen was 28.5%, exceeding the same period of the previous year of 18.9%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to grow 1.5% from the same period last year, reaching 201 million yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit increased 30.4% from the same period last year, reaching 90 million yen. The operating profit margin remained almost flat, changing from 6.6% in the same period last year to 6.6%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2023 | 1,599 | 11 | 7 | -4 | -0.1 | 6.7 | Nov 13, 2023 | J-GAAP |
| Apr - Sep, 2024 | 1,768 | 50 | 46 | 24 | 0.7 | 18.9 | Nov 13, 2024 | J-GAAP |
| Apr - Sep, 2025 | 2,307 | 87 | 80 | 44 | 1.3 | 28.5 | Nov 14, 2025 | J-GAAP |
| YoY | +30.5% | +74.0% | +73.9% | +83.3% | +78.9% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | - | 0 | May 14, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 2,307 | 87 | 80 | 44 | 1.3 | 0 | Nov 14, 2025 | J-GAAP |
| Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 2,579 | 218 | 198 | 157 | 4.5 | 0 | May 14, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 2,493 | 198 | 201 | 182 | 5.2 | 0 | Nov 14, 2025 | J-GAAP |
| YoY | -3.3% | -9.2% | +1.5% | +15.9% | +15.6% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 3,727 | 106 | 104 | 80 | 2.3 | 0 | May 14, 2024 | J-GAAP |
| Mar, 2025 | 4,347 | 268 | 244 | 181 | 5.2 | 0 | May 14, 2025 | J-GAAP |
| Mar, 2026 Guidance | 4,800 | 285 | 281 | 226 | 6.4 | 0 | May 14, 2025 | J-GAAP |
| YoY | +10.4% | +6.3% | +15.2% | +24.9% | +24.4% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 1,050 | 69 | 69 | 52 | 1.5 | 6.6 | Nov 13, 2024 | J-GAAP |
| Oct - Dec, 2024 | 1,006 | 78 | 91 | 70 | 2.0 | 7.8 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 1,573 | 140 | 107 | 87 | 2.5 | 8.9 | May 14, 2025 | J-GAAP |
| Apr - Jun, 2025 | 892 | -6 | -10 | -31 | -0.9 | -0.7 | Aug 14, 2025 | J-GAAP |
| Jul - Sep, 2025 | 1,415 | 93 | 90 | 75 | 2.2 | 6.6 | Nov 14, 2025 | J-GAAP |
| YoY | +34.8% | +34.8% | +30.4% | +44.2% | +40.3% |
Related Articles
RaQualia Pharma, Jan-Sep (Cumulative 3Q) Ordinary Profit Loss Widens, Jul-Sep Ordinary Profit Turns to Loss
SecuAvail, First Half Ordinary Profit Turns to Profit, Jul-Sep Ordinary Profit Turns to Profit
SDS HOLDINGS, First Half Ordinary Profit Turns to Profit, Exceeds Full-Year Plan
Nomura Micro Science, First Half Ordinary Profit Increases by 35 times, Jul-Sep Ordinary Profit Turns to Profit
General Oyster, Jul-Sep (2Q) Ordinary Profit Loss Narrows
Excite Holdings, First Half Net Income Turns to Loss, Jul-Sep Net Income Decreases by 89%
TRE HOLDINGS, First Half Ordinary Profit Increases by 94%
JTP CO, First Half Ordinary Profit Unexpectedly Revised Upward by 30%
MEDLEY, Ordinary Profit Forecast for the Fiscal Year Revised Downward to an Unexpected 46% Decrease
Aplix, Jan-Sep (Cumulative 3Q) Net Income Decreases by 17%, Jul-Sep Net Income Decreases by 24%